AzTrials
AzTrials

COPDPhase 3REWORKNCT01135966

Resistance Training in Patients With Chronic Obstructive Lung Disease (COPD): Whole Body Vibration Versus Conventional Resistance Training

A Phase 3 study testing Conventional resistance training program and Whole body vibration resistance training program in people with COPD, run by University Hospital, Ghent at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pulmonary rehabilitation has been emerged as a recommended standard of care for patients with chronic lung disease based on a growing body of scientific evidence. A set of evidence-based guidelines were published in American College of Chest Physicians (ACCP) and the American Association of Cardiovascular and… Read more about this study

Who is it for?
Ages 40 to 80 years
Conditions the study is for
COPD
What is being tested?
Conventional resistance training program and Whole body vibration resistance training program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
62 participants
Where
1 siteBelgium
Study dates
Apr 2010to Nov 2011
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with COPD candidate for pulmonary rehabilitation
  • Men and female between 40 and 80 years of age
  • Written informed consent to participate

Who cannot join

  • Severe cardiac, neurological and orthopedic co-morbidity interfering with exercise training.
  • Pacemaker
  • Hip, knee of shoulder prosthesis or recently introduced spirals, metal pens, bolts or plates
  • Uncontrolled diabetes, epilepsy or migraine
  • Osteoporotic or metastatic fractures, acute hernia, discopathy, spondylitis

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • University Hospital Ghent

    Ghent

Other trials in Belgium

About this study

Pulmonary rehabilitation has been emerged as a recommended standard of care for patients with chronic lung disease based on a growing body of scientific evidence. A set of evidence-based guidelines were published in American College of Chest Physicians (ACCP) and the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). Since then, the published literature in pulmonary rehabilitation has increased substantially, and other societies have published important statements about pulmonary rehabilitation (eg, the American Thoracic Society and the European Respiratory Society).

In patients with COPD, there is a strong scientific basis for implementing conventional resistance training (CRT) in addition to endurance training. Endurance training, such as walking, is a key component of pulmonary rehabilitation and improves in exercise tolerance and muscular endurance. However, this type of training may not reverse muscle weakness or atrophy. For that reason, strength training seems to be the optimum training modality to increase muscle mass and strength.

Read more

Recently, Whole-Body-Vibration (WBV) training has been promoted as an alternative for resistance training on multigym equipment. In WBV training, the subject stands on a platform that generates vertical sinusoidal vibration, during which static and dynamic exercises can be performed.

The present study is conducted to provide an answer on the following question: will a resistance training program, such as the whole body vibration, be even effective than a conventional resistance training program in patients with COPD.

Conditions
COPD
Being tested
Conventional resistance training program, Whole body vibration resistance training program
Keywords
COPD, Whole Body Vibration training, Conventional resistance training
Medical subject headings
Pulmonary Disease, Chronic Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional resistance training programBehavioural

    Conventional resistance training program is followed.

  • Whole body vibration resistance training programBehavioural

    WBV training on FITVIBE

Study groups in NCT01135966
Study groupRoleWhat they receive
Conventional trainingActive comparatorNot described
Receives: Behavioral: Conventional resistance training program
Whole body vibration trainingExperimentalNot described
Receives: Behavioral: Whole body vibration resistance training program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. estimation of the change of 6 MWD before and after 12 weeks resistance training program (CRT versus WBV training)

    estimation of the change of 6 MWD (submaximal walking test)after a 12 week conventional resistance training program or after a 12 week whole body vibration training program

    Measured: before and after 12 weeks

Secondary outcomes (7)
  1. changes in muscle strength (quadriceps force)after CRT or after WBV training in patients with COPD

    measured by modified Microfet before and after 12 weeks of training.

    Measured: before and after 12 weeks

  2. changes in body composition after CRT or after WBV training in patients with COPD

    measured by bioelectrical impedance analysis: Fat Free Mass (FFM)before and after 12 weeks of training.

    Measured: before and after 12 weeks

  3. changes in maximal exercise capacity after CRT or after WBV training in patients with COPD

    measured by cyclo-ergospirometry before and after 12 weeks of training

    Measured: before and after 12 weeks

  4. changes in muscle force after CRT or after WBV training in patients with COPD

    measured by handgrip force, maximal inspiratory pressure (PImax) and maximal expiratory pressure (PEmax)before and after 12 weeks of training

    Measured: before and after 12 weeks

  5. changes in Quality of life after CRT or after WBV training in patients with COPD

    measured by CRDQ (Chronic Respiratory Disease Questionnaire)before and after 12 weeks of training

    Measured: beforer and after 12 weeks

  6. changes in Dyspnea scores after CRT or after WBV training in patients with COPD

    measured by Chronic Respiratory Disease Questionnaire domain dyspnea (CRDQd) and by the BORG scale before and after 12 weeks of training.

    Measured: before and after 12 weeks

  7. changes in 6MWD and the endurance test on the bicycle after CRT or after WBV training in patients with COPD

    measured by endurance test on the bicycle (75% Max. Workload)before and after 12 weeks of training. This test will also be repeated after 6 weeks of training.

    Measured: before and after 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2010 (estimated)
  2. Study startApr 2010
  3. Primary completionJul 2011
  4. Study completionNov 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
62 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01135966
Sponsor's protocol ID
2010/157
Acronym
REWORK
Status last verified
Dec 2011
First submitted
2 Jun 2010
Last updated
12 Dec 2011
Results posted
No
Data monitoring committee
No

Publications

  • Salhi B, Malfait TJ, Van Maele G, Joos G, van Meerbeeck JP, Derom E. Effects of Whole Body Vibration in Patients With COPD. COPD. 2015;12(5):525-32. doi: 10.3109/15412555.2015.1008693. Epub 2015 Aug 4.

    PubMed 26457458

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Conventional resistance training program and Whole body vibration resistance training program in people with COPD, run by University Hospital, Ghent at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Dec 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

estimation of the change of 6 MWD before and after 12 weeks resistance training program (CRT versus WBV training) (time frame: before and after 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01135966, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in